Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: A phase II trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Urologic Neoplasms

abstract

  • ITP is an active, well-tolerated regimen in previously untreated patients with TCC of the urothelial tract. Further study of this regimen in patients with both TCC and non-transitional-cell urothelial tumors is ongoing.

publication date

  • August 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9704723

Additional Document Info

start page

  • 2722

end page

  • 7

volume

  • 16

number

  • 8